Literature DB >> 12580543

Green fluorescent protein immunohistochemistry as a novel experimental tool for the detection of glioma cell invasion in vivo.

David Zagzag1, Douglas C Miller, Luis Chiriboga, Herman Yee, Elizabeth W Newcomb.   

Abstract

In vivo animal models of primary brain tumors are necessary to advance knowledge related to the complex interactions between glioma cells and the adjacent brain. A cardinal feature of glioma growth, and a major reason why neurosurgical and adjunctive therapies ultimately fail in most patients is their invasive properties. We have adapted a previously described animal model developed by one of us to give better histological detail while preserving the identification of single infiltrating glioma cells. GL261 glioma cells were first transfected with the plasmid encoding green fluorescent protein (GFP) and then implanted into the brains of syngeneic C57BL/6 mice. Identification of GFP-positive tumor cells in paraffin sections of the brains of tumor-bearing animals utilized an antibody for conventional immunoperoxidase immunohistochemistry. This method is a more powerful technique compared with the prior use of frozen sections and fluorescence microscopy to identify GFP-tagged tumor cells. We find that this new method provides improved morphology and proves to be a sensitive and reliable system for detection of invading glioma cells. Using this methodology with other advanced technologies (eg, laser capture microdissection) holds out the promise of helping to elucidate the molecular mechanisms of glioma cell infiltration and invasion into the surrounding brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12580543     DOI: 10.1111/j.1750-3639.2003.tb00004.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  18 in total

1.  Radiotherapy enhances antitumor effect of anti-CD137 therapy in a mouse Glioma model.

Authors:  Elizabeth W Newcomb; Yevgeniy Lukyanov; Noriko Kawashima; Michelle Alonso-Basanta; Shu-Chi Wang; Mengling Liu; Maria Jure-Kunkel; David Zagzag; Sandra Demaria; Silvia C Formenti
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

2.  Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures.

Authors:  David Zagzag; Mine Esencay; Olga Mendez; Herman Yee; Iva Smirnova; Yuanyuan Huang; Luis Chiriboga; Eugene Lukyanov; Mengling Liu; Elizabeth W Newcomb
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

3.  Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti-Vascular Endothelial Growth Factor Therapy-Induced Glioma Dissemination.

Authors:  Jean-Pierre Gagner; Yasmeen Sarfraz; Valerio Ortenzi; Fawaz M Alotaibi; Luis A Chiriboga; Awab T Tayyib; Garry J Douglas; Eric Chevalier; Barbara Romagnoli; Gérald Tuffin; Michel Schmitt; Guillaume Lemercier; Klaus Dembowsky; David Zagzag
Journal:  Am J Pathol       Date:  2017-07-20       Impact factor: 4.307

4.  Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion.

Authors:  Salvatore Coniglio; Ian Miller; Marc Symons; Jeffrey E Segall
Journal:  J Vis Exp       Date:  2016-10-20       Impact factor: 1.355

Review 5.  The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation.

Authors:  Sandra Demaria; Karsten A Pilones; Claire Vanpouille-Box; Encouse B Golden; Silvia C Formenti
Journal:  Radiat Res       Date:  2014-06-17       Impact factor: 2.841

6.  Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.

Authors:  Nadja Osterberg; Napoleone Ferrara; Jean Vacher; Simone Gaedicke; Gabriele Niedermann; Astrid Weyerbrock; Soroush Doostkam; Hans-Eckart Schaefer; Karl H Plate; Marcia Regina Machein
Journal:  Neuro Oncol       Date:  2016-03-06       Impact factor: 12.300

7.  Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.

Authors:  Olga Méndez; Jiri Zavadil; Mine Esencay; Yevgeniy Lukyanov; Daniel Santovasi; Shu-Chi Wang; Elizabeth W Newcomb; David Zagzag
Journal:  Mol Cancer       Date:  2010-06-01       Impact factor: 27.401

8.  Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8.

Authors:  Diana Aguilar-Morante; Jose Angel Morales-Garcia; Marina Sanz-SanCristobal; Miguel Angel Garcia-Cabezas; Angel Santos; Ana Perez-Castillo
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

9.  Utility of human placental alkaline phosphatase as a genetic marker for cell tracking in bone and cartilage.

Authors:  Nina J Unger; Kathrin I Odörfer; Karin Weber; Eric P Sandgren; Reinhold G Erben
Journal:  Histochem Cell Biol       Date:  2007-05-11       Impact factor: 4.304

10.  COX-2 Inhibition Combined with Radiation Reduces Orthotopic Glioma Outgrowth by Targeting the Tumor Vasculature.

Authors:  Michiel Wagemakers; Gesiena E van der Wal; Rosa Cuberes; Inés Alvarez; Eva Ma Andrés; Jordi Buxens; José M Vela; Henk Moorlag; Jan Jakob A Mooij; Grietje Molema
Journal:  Transl Oncol       Date:  2009-03       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.